News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Investing in facilities that allow customers to test biomanufacturing equipment and processes is both cost-effective and necessary due to Biopharma's regulatory demands, say Merck, Pall and GE.
The US Department of Defense has developed a portable, on-demand biopharmaceutical production system that could be used in warzones to make treatments at point-of-care.
ASLAN Pharmaceuticals has contracted Selexis to develop a CHO-K1 cell line to express its monoclonal antibody candidate targeting asthma.